44th week of 2018 patent applcation highlights part 9 |
Patent application number | Title | Published |
20180311265 | Methods and Compositions for Treatment of COPD Diseases | 2018-11-01 |
20180311266 | COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 | 2018-11-01 |
20180311267 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | 2018-11-01 |
20180311268 | RESPONSE-GUIDED HCV THERAPY | 2018-11-01 |
20180311269 | TARGETED CANCER THERAPY | 2018-11-01 |
20180311270 | RNA MOLECULE FOR REPAIRING DNA DAMAGE | 2018-11-01 |
20180311271 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | 2018-11-01 |
20180311272 | Compositions and Methods for Treating Joints | 2018-11-01 |
20180311273 | Method of Treating Inflammation | 2018-11-01 |
20180311274 | IN SITU NEUTRALIZATION COMPOSITION | 2018-11-01 |
20180311275 | Method, Target and Application for NO Accumulation to Decrease Pseudomonas Aeruginosa Invasiveness | 2018-11-01 |
20180311276 | Method and Apparatus for Treating Oral Disease in Animals | 2018-11-01 |
20180311277 | THERAPEUTIC AGENT FOR SKIN WOUND OR ROUGH SKIN | 2018-11-01 |
20180311278 | PHARMACEUTICAL PREPARATION FOR DELIVERY OF POROUS MATERIAL TO LARGE INTESTINE OR LOWER PART OF SMALL INTESTINE | 2018-11-01 |
20180311279 | HERBO-MINERAL FORMULATION FOR PREVENTION, TREATMENT AND MANAGEMENT OF RENAL DISORDERS AND METHOD OF PREPARATION THEREOF | 2018-11-01 |
20180311280 | Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products | 2018-11-01 |
20180311281 | PRIMED MUSCLE PROGENITOR CELLS AND USES THEREOF | 2018-11-01 |
20180311282 | CHAMBER FOR ENCAPSULATING SECRETING CELLS | 2018-11-01 |
20180311283 | PRODUCTS DERIVED FROM AMNIOTIC FLUID AND METHODS OF USE | 2018-11-01 |
20180311284 | AMNIOTIC FLUID TOPICAL FORMULATION | 2018-11-01 |
20180311285 | METHODS FOR THE TREATMENT OF INFLAMMATION AND PAIN USING HUMAN BIRTH TISSUE MATERIAL COMPOSITION | 2018-11-01 |
20180311286 | Method of Committed Differentiation of Human Induced Pluripotent Stem Cells into Leydig Cells and Application of Leydig Cells | 2018-11-01 |
20180311287 | Modulation of Splenocytes in Cell Therapy for Traumatic Brain Injury | 2018-11-01 |
20180311288 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | 2018-11-01 |
20180311289 | INFECTION PROTECTIVE AGENT FOR INFANTS | 2018-11-01 |
20180311290 | MODULATION OF AAV VECTOR TRANSGENE EXPRESSION | 2018-11-01 |
20180311291 | ONCOLYTIC ADENOVIRUSES ARMED WITH HETEROLOGOUS GENES | 2018-11-01 |
20180311292 | PRODUCTS AND METHODS | 2018-11-01 |
20180311293 | Thylakoid Extract Composition and Formulation for the Treatment of Inflammatory Bowel Disease | 2018-11-01 |
20180311294 | COMPOSITION COMPRISING A MIXTURE OF MOLECULES EXTRACTED FROM CHRYSANTHELLUM INDICUM, CYNARA SCOLYMUS AND LYCIUM BARBARUM AND USE TO ACT ON CARBOHYDRATE AND/OR FAT METABOLISM | 2018-11-01 |
20180311295 | METHOD FOR REDUCING WEIGHT | 2018-11-01 |
20180311296 | METHOD FOR EXTRACTING STILBENE COMPOUNDS | 2018-11-01 |
20180311297 | PHARMACEUTICAL COMPOSITION FOR INCREASING CONTENT AND AVAILABILITY OF CYCLIC ADENOSINE MONOPHOSPHATE IN A BODY AND PREPARATION THEREOF | 2018-11-01 |
20180311298 | Composition, and Method of Using the Composition, Effective for Minimizing the Harmful Effects Associated With Individuals Suffering from Alcohol Intoxication | 2018-11-01 |
20180311299 | EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF A KIDNEY TRANSPLANT | 2018-11-01 |
20180311300 | BICYCLIC PEPTIDE LIGANDS AND USES THEREOF | 2018-11-01 |
20180311301 | MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY | 2018-11-01 |
20180311302 | CXCR ANTAGONISTIC PEPTIDES AND USES THEREOF | 2018-11-01 |
20180311303 | Materials and Methods for Treatment of Inflammation | 2018-11-01 |
20180311304 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION AND ANXIETY | 2018-11-01 |
20180311305 | LOW-BURST POLYMERS AND METHODS TO PRODUCE POLYMER | 2018-11-01 |
20180311306 | METHODS FOR TREATING HYPOTENSION | 2018-11-01 |
20180311307 | THERAPEUTIC VITAMIN D CONJUGATES | 2018-11-01 |
20180311308 | METHODS OF TREATING MYELOID LEUKEMIA | 2018-11-01 |
20180311309 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | 2018-11-01 |
20180311310 | THERAPEUTIC & DIAGNOSTICS COMPOSITIONS TARGETING TOLL-LIKE RECEPTORS AND METHODS THEREOF | 2018-11-01 |
20180311311 | METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION | 2018-11-01 |
20180311312 | Use of a Neuregulin to Treat Peripheral Nerve Injury | 2018-11-01 |
20180311313 | COMPOSITION HAVING TISSUE-REPAIRING ACTIVITY, AND USE THEREFOR | 2018-11-01 |
20180311314 | Glucokinase Activator Compositions for the Treatment of Diabetes | 2018-11-01 |
20180311315 | LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST | 2018-11-01 |
20180311316 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | 2018-11-01 |
20180311317 | Factor VIII Sequences | 2018-11-01 |
20180311318 | METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL DISORDERS | 2018-11-01 |
20180311319 | TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS | 2018-11-01 |
20180311320 | USE OF RECOMBINANT HUMAN CALCINEURIN B SUBUNIT | 2018-11-01 |
20180311321 | ASSISTED ENZYME REPLACEMENT THERAPY | 2018-11-01 |
20180311322 | METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE THROMBOLYSIS | 2018-11-01 |
20180311323 | METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE | 2018-11-01 |
20180311324 | METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS | 2018-11-01 |
20180311325 | CHEMICALLY MODIFIED CYSTATHIONINE BETA-SYNTHASE ENZYME FOR TREATMENT OF HOMOCYSTINURIA | 2018-11-01 |
20180311326 | IMMUNOASSEMBLIN (IA) PROTEIN COMPLEXES | 2018-11-01 |
20180311327 | AQUAPORIN 2 PROTECTS CATTLE FROM TICKS AND TICK-BORNE PARASITES | 2018-11-01 |
20180311328 | Peptide Selection Method | 2018-11-01 |
20180311329 | VACCINES AGAINST ANTIGENS INVOLVED IN THERAPY RESISTANCE AND METHODS OF USING SAME | 2018-11-01 |
20180311330 | Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) | 2018-11-01 |
20180311331 | PROGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMAS | 2018-11-01 |
20180311332 | NEOSPORA VACCINE COMPOSITION | 2018-11-01 |
20180311333 | Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect | 2018-11-01 |
20180311334 | Compositions and Methods for Inducing an Immune Response | 2018-11-01 |
20180311335 | CELL SURFACE ANCHORING ANTIGEN CONJUGATES TO TREAT CANCER | 2018-11-01 |
20180311336 | BROAD SPECTRUM INFLUENZA VIRUS VACCINE | 2018-11-01 |
20180311337 | MDCK SUSPENSION CELL LINES IN SERUM-FREE, CHEMICALLY-DEFINED MEDIA FOR VACCINE PRODUCTION | 2018-11-01 |
20180311338 | MICRONEEDLE COMPOSITIONS AND METHODS OF USING SAME | 2018-11-01 |
20180311339 | Compositions and Methods for the Treatment or Prevention of Hepatitis B Virus Infection | 2018-11-01 |
20180311340 | NEW ADJUVANT AND VACCINE COMPOSITION CONTAINING THE SAME | 2018-11-01 |
20180311341 | METHOD FOR ENHANCING GENERATION OF ANTIGEN-SPECIFIC CYTOTOXIC T LYMPHOCYTES (CTL) AND ANTIBODIES | 2018-11-01 |
20180311342 | IMMUNOSTIMULATING AGENT | 2018-11-01 |
20180311343 | MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF | 2018-11-01 |
20180311344 | MATERIALS AND METHODS FOR MODULATING IMMUNE RESPONSES | 2018-11-01 |
20180311345 | A METHOD OF INHIBITING EXACERBATIONS OF T CELL-MEDIATED ALLOGRAFT VASCULOPATHY | 2018-11-01 |
20180311346 | COMBINATION THERAPY OF IMMUNOTOXIN AND CHECKPOINT INHIBITOR | 2018-11-01 |
20180311347 | POLYMORPHISMS IN CACHEXIA PREDICT CLINICAL OUTCOMES OF COLORECTAL CANCER PATIENTS RECEIVING IRINOTECAN AND BEVACIZUMAB | 2018-11-01 |
20180311348 | TRISPECIFIC MOLECULE COMBINING SPECIFIC TUMOR TARGETING AND LOCAL IMMUNE CHECKPOINT INHIBITION | 2018-11-01 |
20180311349 | STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB | 2018-11-01 |
20180311350 | STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB | 2018-11-01 |
20180311351 | STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB | 2018-11-01 |
20180311352 | STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB | 2018-11-01 |
20180311353 | TRIPLET-TRIPLET ANNIHILATION-BASED UPCONVERSION | 2018-11-01 |
20180311354 | IMMUNOMAGNETIC NANOCAPSULE, PHARMACEUTICAL COMPOSITION THEREOF FOR TREATING CANCER AND KIT FOR TREATING CANCER | 2018-11-01 |
20180311355 | METHODS FOR RADIOTHERAPY TO TRIGGER LIGHT ACTIVATION DRUGS | 2018-11-01 |
20180311356 | METHOD TO INHIBIT ENDOTHELIAL-TO-MESENCHYMAL TRANSITION | 2018-11-01 |
20180311357 | EXTERNAL PREPARATION AND METHOD FOR PRODUCING SAME | 2018-11-01 |
20180311358 | THERMOFORMABLE DUAL NETWORK HYDROGEL COMPOSITIONS | 2018-11-01 |
20180311359 | Antibody Formulations and Uses Thereof | 2018-11-01 |
20180311360 | Sprayable Topical Carrier and Composition Comprising Phosphatidylcholine | 2018-11-01 |
20180311361 | Compositions | 2018-11-01 |
20180311362 | TRANSDERMAL ABSORPTION PREPARATION | 2018-11-01 |
20180311363 | TRANSDERMAL ABSORPTION PREPARATION PRECURSOR | 2018-11-01 |
20180311364 | Protease Triggered Release Of Molecules From Hydrogels | 2018-11-01 |